,,ii  #aad? ,,congress  #b;d ,session   
,s4 #cagf  ,,9 ,,! ,,s5ate ,,( ,,!      
,,unit$ ,,/ates  ,july #ac1 #bjaf,mr4   
,br[n introduc$ ! foll[+ bill2 :i* 0    
read twice & ref]r$ to ! ,committee on  
,heal?1 ,education1 ,labor1 & ,p5sions  
,a ,,bill  ,to am5d ! ,public ,heal?    
,s]vice ,act to enhance ef=ts to address
 antibiotic resi/ance1 & = o!r purposes4
  #a4 ,%ort title ,?is ,act may be cit$ 
z ! ,/rategies to ,address ,antibiotic  
,resi/ance ,act or ! ,,/a> ,act4  #b4   
,f9d+s ,congress makes ! foll[+ f9d+s3  
7#a7 ,! adv5t ( ! antibiotic era has    
sav$ millions ( lives & all[$ =         
incr$ible m$ical progress2 h[ev]1 !     
increas$ use & ov]use ( antibiotic drugs
 h correlat$ ) increas$ rates (         
antibiotic resi/ance4  7#b7 ,?r\gh      
mutation z well z o!r me*anisms1 bact]ia
 develop resi/ance to antibiotic drugs  
ov] "t4 ,ov]use & o!r inappropriate use 
( antibiotics less5 _! effectiv5ess &   
contribute to ! developm5t ( antibiotic 
resi/ance4  7#c7 ,sci5tific evid5ce     

sugge/s t ! developm5t ( antibiotic     
resi/ance 9 human pa?og5s is due n only 
to use ( antibiotic drugs 9 humans1 b   
also may be caus$ by ! use ( antibiotics
 9 food-produc+ animals4  7#d7 ,ea* ye>1
 ne>ly #b1jjj1jjj p become infect$ )    
bact]ia t are resi/ant to antibiotics & 
at lea/ #bc1jjj p die z a result ( su*  
infections4 ,_m m die f o!r conditions t
 7 complicat$ by an antibiotic-resi/ant 
infection4  7#e7 ,accord+ to a #bjac    
report f ! ,c5t]s = ,disease ,control & 
,prev5tion1 c>bap5em-resi/ant           
,ent]obact]iaceae 7,,cre7 bact]ia are on
 ! rise among pati5ts 9 m$ical          
facilities4 ,,cre bact]ia h become      
resi/ant to all or ne>ly all !          
antibiotics curr5tly available4         
,invasive infections1 su* z a blood/ream
 infection1 ) ,,cre bact]ia are         
associat$ ) mortality rates exce$+ #dj  
p]c5t4  7#f7 ,a #bjab /udy conduct$ at  
,columbia ,univ]sity 7,cl9ical          
,infecti\s ,disease1 ,septemb] #bjab7   
f\nd t ea* antibiotic-resi/ant infection

 co/s1 on av]age1 ov] #ae1jjj m to treat
 ?an antibiotic-susceptible infections4 
7#g7 ,! co/s ( antibiotic-resi/ant      
infections 9 t]ms ( lives lo/ & !       
economy w only rise z antibiotic        
resi/ance cont9ues to spread4  7#h7     
,antibiotic resi/ance is "o ( ! greate/ 
?reats to human heal? worldwide1 call+ =
 increas$ prev5tion1 antibiotic         
/ew>d%ip1 surveillance1 & rese>* &      
developm5t = new antibiotics & rapid    
diagno/ics4  7#i7 ,! ,presid5t's        
,national ,action ,plan = ,combat+      
,antibiotic-,resi/ant ,bact]ia1 issu$ 9 
,m>* #bjae 7ref]r$ to 9 ?is section z ! 
,action ,plan71 :i* 0 develop$ 9        
response to ,executive ,ord] #acfgf1    
dat$ ,septemb] #ah1 #bjad 7#gi ,f$4     
,reg4 #efica2 relat+ to combat+         
antibiotic-resi/ant bact]ia71 outl9es   
specific /eps to address antibiotic     
resi/ance4  7#aj7 ,! ,action ,plan      
includes ! dome/ic & int]national ef=ts 
( ! ,unit$ ,/ates to prev5t1 detect1 &  
control illness & dea? relat$ to        

infections caus$ by antibiotic-resi/ant 
bact]ia by implem5t+ measures to        
mitigate ! em]g5ce & spread ( antibiotic
 resi/ance & ensur+ ! cont9u$           
availability ( !rapeutics = ! treatm5t (
 bact]ial infections4  7#aa7 ,misuse &  
ov]use ( antibiotics has contribut$ to  
antibiotic resi/ance4 ,a rec5t /udy on  
antibiotic prescrib+ practices f\nd t #a
 9 #c antibiotic prescriptions 7 det]m9$
 unnecess>y or inappropriate4  #c4 ,task
 =ce = combat+ antibiotic-resi/ant      
bact]ia2 advisory c\ncil on combat+     
antibiotic-resi/ant bact]ia  7a7 ,task  
=ce ,section #cai;,e ( ! ,public ,heal? 
,s]vice ,act 7#db ,u4,s4,c4 #bdg;d-#e7  
is am5d$--  7#a7 9 subsection 7a7-- 7,a7
 9 p>agraph 7#a71 by /rik+ ,! ,secret>y 
%all e/abli% & ins]t+ ,9 accordance ) ! 
objectives ( ,executive ,ord] #acfgf1   
dat$ ,septemb] #ah1 #bjad 7#gi ,f$4     
,reg4 #efica2 relat+ to combat+         
antibiotic-resi/ant bact]ia71 !         
,secret>y %all e/abli%2  7,b7 by am5d+  
p>agraph 7#b7 to read z foll[s3  7#b7   

,memb]s ( ! antimicrobial resi/ance task
 =ce ,! task =ce describ$ 9 p>agraph    
7#a7 %all be co-*air$ by ! ,secret>ies (
 ,heal? & ,human ,s]vices1 ,agriculture1
 & ,def5se1 & %all be compos$ (         
repres5tatives ( relevant ,f$]al ag5cies
 & su* executive dep>tm5ts1 ag5cies1 or 
(fices z ! co-*airs may designate4  2   
7,c7 by am5d+ p>agraph 7#d7 to read z   
foll[s3  7#d7 ,meet+s ,at lea/ twice a  
ye>1 ! task =ce describ$ 9 p>agraph 7#a7
 %all h a public meet+ to assess        
progress & ob/acles to implem5t+ !      
,presid5t's ,national ,action ,plan =   
,combat+ ,antibiotic-,resi/ant ,bact]ia1
 issu$ 9 ,m>* #bjae 7ref]r$ to 9 ?is    
section z ! ,action ,plan74 ,among o!r  
issues1 ! task =ce may discuss & review1
 bas$ on ne$ or conc]n--  7,a7 ,f$]al   
activities to sl[ ! em]g5ce ( resi/ant  
bact]ia & prev5tion ( ! spread (        
resi/ant infections1 includ+ promotion (
 ! optimal use ( vacc9es to prev5t      
infections1 & implem5tation ( heal? c>e 
policies & antibiotic /ew>d%ip programs 

t improve pati5t outcomes2  7,b7 ,f$]al 
activities to /r5g!n national ,"o-,heal?
 surveillance ef=ts z describ$ 9 !      
,action ,plan to combat resi/ance1      
includ+ enhancem5t & integration ( data 
f surveillance sy/ems t monitor human   
pa?og5s1 includ+ ! ,national ,heal?c>e  
,safety ,network1 ! ,em]g+ ,infections  
,program1 & ! ,national ,antimicrobial  
,resi/ance ,monitor+ ,sy/em1 ) data f   
surveillance sy/ems t monitor animal    
pa?og5s1 includ+ ! ,national ,animal    
,heal? ,monitor+ ,sy/em1 ! ,national    
,animal ,heal? ,laboratory ,network1 & !
 ,vet]9>y ,laboratory ,inve/igation &   
,response ,network2  7,c7 ,f$]al ef=ts  
to advance ! developm5t & use ( rapid & 
innovative diagno/ic te/s =             
id5tification & *>act]ization ( resi/ant
 bact]ia2  7,d7 ,f$]al ef=ts to         
accel]ate basic & appli$ rese>* &       
developm5t = new antibiotics1 o!r       
!rapeutics1 & vacc9es2 &  7,e7          
improvem5ts 9 int]national collaboration
 & capacities = antibiotic-resi/ance    

prev5tion1 surveillance1 control1 &     
antibiotic rese>* & developm5t4  2 &    
7,d7 by add+ at ! end ! foll[+3  7#e7   
,availability ( in=mation ,! task =ce1  
to ! ext5t p]mitt$ by law1 %all--  7,a7 
provide ! ,advisory ,c\ncil describ$ 9  
section #cai;,e-#a ) su* in=mation z may
 be requir$ = c>ry+ out ! functions (   
su* ,advisory ,c\ncil1 includ+ in=mation
 on progress 9 advanc+ ! ,action ,plan1 
meet+ m9utes1 & o!r key in=mation ( !   
task =ce2 &  7,b7 ensure t all in=mation
 describ$ 9 subp>agraph 7,a7 is made    
available on ! websites ( ! ,dep>tm5t ( 
,heal? & ,human ,s]vices1 ! ,dep>tm5t ( 
,agriculture1 & ! ,dep>tm5t ( ,def5se4  
2 &  7#b7 by add+ at ! end ! foll[+3    
7h7 ,annual progress report to ,congress
 on implem5tation ( national action plan
 = combat+ antibiotic-,resi/ant bact]ia 
,n lat] ?an #a ye> aft] ! date ( !      
enactm5t ( ! ,/rategies to ,address     
,antibiotic ,resi/ance ,act1 & annually 
!reaft]1 ! ,secret>y1 9 coop]ation ) !  
,secret>y ( ,agriculture1 ! ,secret>y ( 

,def5se1 & ! task =ce describ$ 9        
subsection 7a7 %all submit to !         
,committee on ,heal?1 ,education1       
,labor1 & ,p5sions ( ! ,s5ate & !       
,committee on ,en]gy & ,comm]ce ( !     
,h\se ( ,repres5tatives1 & make         
available on ! websites ( ! ,dep>tm5t ( 
,heal? & ,human ,s]vices1 ! ,dep>tm5t ( 
,agriculture1 & ! ,dep>tm5t ( ,def5se1 a
 report on ! progress made 9 implem5t+ !
 goals ( ! ,action ,plan4  4  7b7       
,advisory c\ncil ,"p ,b ( title ,,iii ( 
! ,public ,heal? ,s]vice ,act 7#db      
,u4,s4,c4 #bdc et seq47 is am5d$ by     
ins]t+ aft] section #cai;,e ! foll[+3   
#cai;,e-#a4 ,presid5tial ,advisory      
,c\ncil on ,combat+                     
,antibiotic-,resi/ant ,bact]ia  7a7 ,9  
g5]al ,! ,presid5tial ,advisory ,c\ncil 
on ,combat+ ,antibiotic-,resi/ant       
,bact]ia e/abli%$ ?r\gh ,executive ,ord]
 #acfgf1 dat$ ,septemb] #ah1 #bjad 7#gi 
,f$4 ,reg4 #efica2 relat+ to combat+    
antibiotic-resi/ant bact]ia7 7ref]r$ to 
9 ?is section z ! ,advisory ,c\ncil71   

%all provide advice1 in=mation1 &       
recomm5dations to ! ,secret>y reg>d+    
programs & policies int5d$ to support & 
evaluate ! implem5tation ( su*          
,executive ,ord] #acfgf1 includ+ !      
,national ,/rategy = ,combat+           
,antibiotic-,resi/ant ,bact]ia & !      
,presid5t's ,national ,action ,plan =   
,combat+ ,antibiotic-,resi/ant ,bact]ia1
 issu$ 9 ,m>* #bjae4  7b7 ,meet+s &     
duties  7#a7 ,meet+s ,! ,advisory       
,c\ncil %all meet z ! ,*air det]m9es to 
be appropriate b n less ?an twice p]    
ye>1 &1 to ! ext5t practicable1 9       
conjunction ) meet+s ( ! task =ce       
describ$ 9 section #cai;,e4  7#b7       
,recomm5dations ,! ,advisory ,c\ncil    
%all make recomm5dations to ! ,secret>y1
 9 consultation ) ! ,secret>y (         
,agriculture & ! ,secret>y ( ,def5se1   
reg>d+ programs & policies int5d$ to--  
7,a7 pres]ve ! effectiv5ess (           
antibiotics by optimiz+ _! use2  7,b7   
advance rese>* to develop improv$ me?ods
 = combat+ antibiotic resi/ance &       

conduct+ antibiotic /ew>d%ip2  7,c7     
/r5g!n surveillance (                   
antibiotic-resi/ant bact]ial infections2
  7,d7 prev5t ! transmission (          
antibiotic-resi/ant bact]ial infections2
  7,e7 advance ! developm5t ( rapid     
po9t-(-c>e & agricultural diagno/ics2   
7,f7 fur!r rese>* on new treatm5ts =    
bact]ial infections2  7,g7 develop      
alt]natives to antibiotics =            
agricultural purposes2  7,h7 maximize ! 
dissem9ation ( up-to-date in=mation on !
 appropriate & prop] use ( antibiotics  
to ! g5]al public & human & animal heal?
 c>e provid]s2 &  7,i7 improve          
int]national coord9ation ( ef=ts to     
combat antibiotic resi/ance4  4  #d4    
,surveillance & report+ ( antibiotic use
 & resi/ance ,"p ,b ( title ,,iii ( !   
,public ,heal? ,s]vice ,act 7#db        
,u4,s4,c4 #bdc et seq471 z am5d$ by     
section #c7;b71 is fur!r am5d$ by ins]t+
 aft] section #cai;,e-#a ! foll[+3      
#cai;,e-#b4 ,surveillance & report+ (   
antibiotic use & resi/ance  7a7 ,9 g5]al

 ,! ,secret>y1 act+ ?r\gh ! ,director ( 
! ,c5t]s = ,disease ,control &          
,prev5tion1 %all use ! ,national        
,heal?c>e ,safety ,network & o!r        
appropriate surveillance sy/ems to      
assess--  7#a7 appropriate conditions1  
outcomes1 & measures causally relat$ to 
antibact]ial resi/ance1 includ+ types ( 
infections1 ! causes = infections1 &    
:e!r infections are acquir$ 9 a         
community or hospital sett+1 increas$   
l5g?s ( hospital /ay1 increas$ co/s1 &  
rates ( mortality2 &  7#b7 *anges 9     
bact]ial resi/ance to drugs 9 relation  
to pati5t outcomes1 includ+ *anges 9    
p]c5t resi/ance1 preval5ce (            
antibiotic-resi/ant infections1 & o!r   
su* *anges4  7b7 ,antibiotic use data ,!
 ,director ( ! ,c5t]s = ,disease        
,control & ,prev5tion %all "w ) ,f$]al  
ag5cies 7includ+ ! ,dep>tm5t ( ,vet]ans 
,affairs & ! ,dep>tm5t ( ,def5se71      
private v5dors1 heal? c>e organizations1
 ph>macy b5efit manag]s1 & o!r entities 
z appropriate to obta9 reliable &       

comp>able human antibiotic drug         
consumption data 7includ+1 z available &
 appropriate1 volume antibiotic         
di/ribution data & antibiotic use1      
includ+ prescription data7 by ,/ate or  
metropolitan areas4  7c7 ,antibiotic    
resi/ance tr5d data ,! ,director ( !    
,c5t]s = ,disease ,control & ,prev5tion 
%all int5sify & exp& ef=ts to collect   
antibiotic resi/ance data & enc\rage    
adoption ( ! antibiotic resi/ance & use 
module )9 ! ,national ,heal?c>e ,safety 
,network among all heal? c>e facilities 
across ! cont9uum ( c>e1 includ+1 z     
appropriate1 acute c>e hospitals1       
dialysis facilities1 nurs+ homes1 &     
ambulatory surgical c5t]s4 ,! ,director 
%all seek to collect data f electronic  
m$ication adm9i/ration reports &        
laboratory sy/ems to produce regul>     
reports on antibiotic resi/ance patt]ns 
& antibiotic use4  7d7 ,public          
availability ( data ,! ,secret>y1 act+  
?r\gh ! ,director ( ! ,c5t]s = ,disease 
,control & ,prev5tion1 %all1 = !        

purposes ( improv+ ! monitor+ (         
important tr5ds 9 pati5t outcomes 9     
relation to antibact]ial resi/ance--    
7#a7 make ! data d]iv$ f surveillance "u
 ?is section publicly available on a    
regul> basis t is n less ?an annually2 &
  7#b7 exam9e opportunities to make su* 
data available 9 ne> real "t4  4  #e4   
,detect network ( antibiotic resi/ance  
regional laboratories  7a7 ,9 g5]al ,!  
,secret>y ( ,heal? & ,human ,s]vices1   
act+ ?r\gh ! ,director ( ! ,c5t]s =     
,disease ,control & ,prev5tion1 %all    
e/abli% n less ?an #g ,antibiotic       
,resi/ance ,surveillance & ,laboratory  
,network sites1 build+ ^u ! intramural &
 extramural programs & laboratories ( ! 
,c5t]s = ,disease ,control & ,prev5tion1
 to int5sify1 /r5g!n1 & exp& ! national 
capacity to--  7#a7 monitor ! em]g5ce & 
*anges 9 ! patt]ns ( antibiotic-resi/ant
 bact]ia2  7#b7 describe1 confirm1 &1 z 
necess>y1 facilitate a response to1     
local or regional outbreaks ( resi/ant  
bact]ia2  7#c7 assess & describe        

antibiotic resi/ance patt]ns to in=m    
public heal? & improve prev5tion        
practices2  7#d7 obta9 isolates (       
pa?og5s1 & 9 p>ticul>1 bact]ia t %[ new 
or atypical patt]ns ( resi/ance adv]sely
 affect+ public heal?2  7#e7 assi/ 9    
/udy+ ! epidemiology ( infections f su* 
pa?og5s2  7#f7 evaluate commonly us$    
antibiotic susceptibility te/+ me?ods to
 improve ! accuracy ( resi/ance te/+ &  
report+2  7#g7 z necess>y1 develop or   
evaluate novel diagno/ic te/s capable ( 
detect+ new or em]g+ resi/ance 9        
bact]ia2  7#h7 l9k data g5]at$ by       
regional laboratory networks "u exi/+   
public heal? surveillance networks &    
relevant gov]nm5t ag5cies2 &  7#i7      
provide laboratory assi/ance & ref]5ce  
te/+ ( antibiotic-resi/ant bact]ia to   
enhance infection control & facilitate  
outbreak detection & response 9 heal?   
c>e & community sett+s4  7b7 ,geographic
 di/ribution ,! sites e/abli%$ "u       
subsection 7a7 %all be geographically   
di/ribut$ across ! ,unit$ ,/ates4  7c7  

,nonduplication ( curr5t national       
capacity ,! sites e/abli%$ "u subsection
 7a7 may be bas$ 9 academic c5t]s1 heal?
 dep>tm5ts1 & exi/+ surveillance &      
laboratory sites4  #f4 ,cl9ical trials  
network on antibact]ial resi/ance  7a7  
,9 ,g5]al ,! ,secret>y ( ,heal? & ,human
 ,s]vices1 act+ ?r\gh ! ,director ( !   
,national ,in/itute ( ,all]gy &         
,infecti\s ,diseases1 %all ma9ta9 a     
,cl9ical ,trials ,network on            
,antibact]ial ,resi/ance to enhance1    
/r5g!n1 & exp& rese>* on cl9ical sci5ce1
 antibact]ial & diagno/ic developm5t1 & 
optimal usage /rategies1 & %all1 at a   
m9imum--  7#a7 facilitate rese>* to     
bett] und]/& resi/ance me*anisms & h[ to
 prev5t1 control1 & treat resi/ant      
organisms2  7#b7 l9k data g5]at$ by     
regional laboratory networks "u exi/+   
public heal? surveillance networks &    
indu/ry2  7#c7 advance cl9ical trial    
ef=ts to develop antibiotics diagno/ics1
 & evaluate & optimize ! usage ( su*    
antibiotics2  7#d7 conduct cl9ical      

rese>* to develop natural hi/ories (    
resi/ant infecti\s diseases2  7#e7      
exam9e pati5t outcomes ) curr5tly       
available antibiotic !rapy & validate & 
improve ^u biom>k]s & o!r surrogate     
endpo9ts2 &  7#f7 /udy %ort] treatm5t   
duration & e>ly cessation ( antibiotic  
!rapy = treatm5t efficacy & effect on   
developm5t ( resi/ance4  7b7 ,antibiotic
 resi/ance lead]%ip gr\p ,! ,secret>y ( 
,heal? & ,human ,s]vices1 act+ ?r\gh !  
,director ( ! ,national ,in/itute (     
,all]gy & ,infecti\s ,diseases1 %all    
ma9ta9 an antibiotic resi/ance lead]%ip 
gr\p 7ref]r$ to 9 ?is section z !       
lead]%ip gr\p7 to advance ! developm5t &
 implem5tation ( a compreh5sive cl9ical 
rese>* ag5da to address antibact]ial    
resi/ance t takes into consid]ation !   
recomm5dations conta9$ 9 ! ,presid5t's  
,national ,action ,plan = ,combat+      
,antibiotic-,resi/ant ,bact]ia1 issu$ 9 
,m>* #bjae4 ,! lead]%ip gr\p %all       
provide support = ! foll[+ compon5ts--  
7#a7 sci5tific lead]%ip & op]ations2    

7#b7 cl9ical /udies design &            
implem5tation2  7#c7 network            
laboratories2 &  7#d7 /ati/ical & data  
managem5t4  7c7 ,appropriations ,!re are
 au?oriz$ to be appropriat$ to c>ry out 
?is section su* sums z may be necess>y =
 ea* ( fiscal ye>s #bjag ?r\gh #bjbc4   
#g4 ,regional prev5tion collaborative   
ef=ts ,! ,secret>y ( ,heal? & ,human    
,s]vices1 act+ ?r\gh ! ,director ( !    
,c5t]s = ,disease ,control & ,prev5tion1
 %all "w ) ,/ate & local heal? dep>tm5ts
 to support ! expansion ( collaborative 
ef=ts by gr\ps ( heal? c>e facilities t 
focus on prev5t+ ! spread (             
antibiotic-resi/ant bact]ia t pose a    
s]i\s ?reat to public heal?1 & t are    
design$ to int]rupt & prev5t !          
transmission ( significant              
antibiotic-resi/ant pa?og5s be+         
transmitt$ across heal? c>e sett+s 9 a  
geographic region4 ,su* collaborative   
ef=ts %all--  7#a7 id5tify significant  
drug resi/ant pa?og5s be+ transmitt$    
across heal? c>e sett+s locally2  7#b7  

implem5t evid5ce-bas$ int]v5tions to    
int]rupt & prev5t ! transmission (      
infections associat$ ) heal? c>e &      
antibiotic-resi/ant /ra9s ( bact]ia1    
includ+ evid5ce-bas$ transmission       
prev5tion guidel9es1 rigor\s h& hygi5e  
protocols1 & infection control &        
prev5tion measures2  7#c7 assess        
compliance & id5tify b>ri]s to adh]5ce  
to su* measures2  7#d7 evaluate ! impact
 ( su* measures on hospital             
readmissions1 9 heal? c>e facilities    
across ! cont9uum ( c>e1 rates ( heal?  
c>e associat$ infections1 or any o!r    
relevant measures t *>act]ize ! heal? or
 economic impact ( ! collaborative      
ef=ts2 &  7#e7 provide recomm5dations = 
improv$ outcomes & compliance ) su*     
measures4  #h4 ,prev5tion ,epic5t]s  7a7
 ,9 g5]al ,to provide ! regional        
prev5tion collaborative ef=ts e/abli%$  
"u section #g ) tools1 /rategies1 &     
evid5ce-bas$ int]v5tions1 ! ,director ( 
! ,c5t]s = ,disease ,control &          
,prev5tion may int5sify & exp& academic 

public heal? p>tn]%ips ?r\gh ! "w ( !   
,prev5tion ,epic5t]s ,program ( ! ,c5t]s
 = ,disease ,control & ,prev5tion4 ,!   
,c5t]s = ,disease ,control & ,prev5tion 
& ! epic5t]s p>ticipat+ 9 su* program   
%all "w ) entities1 includ+ ! regional  
prev5tion collaborative ef=ts1 to--     
7#a7 evaluate new & exi/+ int]v5tions to
 prev5t or limit infection rates 9 heal?
 c>e facilities across ! cont9uum ( c>e 
& 9 community sett+s2  7#b7 facilitate  
public heal? rese>* on ! prev5tion &    
control ( resi/ant organisms2 &  7#c7   
assess ! feasibility1 co/ effectiv5ess1 
& appropriat5ess ( surveillance &       
prev5tion programs 9 diff]+ heal? c>e & 
in/itutional sett+s4  7b7 ,educational  
mat]ials ,! ,c5t]s = ,disease ,control &
 ,prev5tion %all use ! rese>* & evid5ce 
f ! epic5t]s p>ticipat+ 9 ! ,prev5tion  
,epic5t]s ,program to create &          
dissem9ate educational mat]ials focus$  
on infection prev5tion & control = use 9
 heal? c>e facilities across ! cont9uum 
( c>e & 9 community sett+s4  #i4        

,cont9uation ( curr5t programs          
,subsection 7g7 ( section #cai;,e ( !   
,public ,heal? ,s]vice ,act 7#db        
,u4,s4,c4 #bdg;d-#e7 is am5d$ by /rik+  
#dj1jjj1jjj & all t foll[s ?r\gh ! p]iod
 at ! end & ins]t+ su* sums z may be    
necess>y = ea* ( ! fiscal ye>s #bjag    
?r\gh #bjba44  #aj4 ,protection (       
confid5tial & national security         
in=mation ,except z o!rwise requir$ by  
law1 ?is ,act 7& ! am5dm5ts made by ?is 
,act7 %all n be con/ru$ to p]mit an     
o!rwise-prohibit$ disclosure ( trade    
secrets1 confid5tial comm]cial          
in=mation1 or mat]ial inconsi/5t )      
national security t is obta9$ by any    
p]son "u ?is ,act 7or any am5dm5t made  
by ?is ,act74